发明名称 MODIFIED RNAI POLYNUCLEOTIDES AND USES THEREOF
摘要 <p>The invention relates to improved RNAi constructs and uses thereof. The construct has a double stranded region of 19-49 nucleotides, preferably 25, 26, or 27 nucleotides, and preferably blunt-ended. The construct has selective minimal modifications to confer an optimal balance of biological activity, toxicity, stability, and target gene specificity. For example, the sense strand may be modified (e.g., one or both ends of the sense strand is/are modified by four 2'-O-methyl groups), such that the construct is not cleaved by Dicer or other RNAse III, and the entire length of the antisense strand is loaded into RISC. In addition, the antisense strand may also be modified by 2'-O-methyl group at the 2nd 5'-end nucleotide to greatly reduce off-target silencing. The constructs of the invention largely avoids the interferon response and sequence- independent apoptosis in mammalian cells, exhibits better serum stability, and enhanced target specificity.</p>
申请公布号 WO2009102427(A2) 申请公布日期 2009.08.20
申请号 WO2009US00852 申请日期 2009.02.11
申请人 RXI PHARMACEUTICALS CORP.;PAVCO, PAMELA, A.;KAMENS, JOANNE;WOOLF, TOD, M.;SALOMON, WILLIAM;KHVOROVA, ANASTASIA 发明人 PAVCO, PAMELA, A.;KAMENS, JOANNE;WOOLF, TOD, M.;SALOMON, WILLIAM;KHVOROVA, ANASTASIA
分类号 A61K31/713;C07H21/02;C12N15/113 主分类号 A61K31/713
代理机构 代理人
主权项
地址